Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyptrophic lateral sclerosis

Antioxidants and Redox Signaling

Volumn 8, Issue 5-6, 2006, Pages 847-867

  Furukawa, Yoshiaki ^a,b   O'Halloran, Thomas V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; DISULFIDE; ENZYME; ISOMERASE; METAL; OXYGEN; POLYPEPTIDE; PROTEIN CCS; THIOL DERIVATIVE; THIOL OXIDASE; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; CATION TRANSPORT; CROSS LINKING; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISULFIDE BOND; ENZYME ACTIVATION; ENZYME METABOLISM; ENZYME MODIFICATION; ENZYME STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; METAL BINDING; METALLATION; MOLECULAR MODEL; MUTATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; REDUCTION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DIMERIZATION; DISULFIDES; ENZYME ACTIVATION; HUMANS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MUTATION; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUPEROXIDE DISMUTASE; ZINC;

EID: 33745821631     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.847     Document Type: Review

References (196)

1. Abernethy JL, Steinman HM, and Hill RL. Bovine erythrocyte superoxide dismutase. Subunit structure and sequence location of the intrasubunit disulfide bond. J Biol Chem 249: 7339-7347, 1974.
2. Ahmad S, Gromiha M, Fawareh H, and Sarai A. ASAView: database and tool for solvent accessibility representation in proteins. BMC Bioinformatics 5: 51, 2004.
3. Andreassen OA, Dedeoglu A, Klivenyi P, Beal MF, and Bush AI. N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport 11: 2491-2493, 2000.
4. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, and Abe K. Mild ALS in Japan associated with novel SOD mutation. Nat Genet 5: 323-324, 1993.
5. Arai K, Iizuka S, Tada Y, Oikawa K, and Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 924: 292-296, 1987.
6. Arnesano F, Banci L, Bertini I, Martinelli M, Furukawa Y, and O'Halloran TV. The unusually stable quaternary structure of human SOD1 is controlled by both metal occupancy and disulfide status. J Biol Chem 279: 47998-48003, 2004.
7. Asayama K and Burr IM. Rat superoxide dismutases. Purification, labeling, immunoassay, and tissue concentration. J Biol Chem 260: 2212-2217, 1985.
8. Banci L, Benedetto M, Bertini I, Del Conte R, Piccioli M, and Viezzoli MS. Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme? Biochemistry 37: 11780-11791, 1998.
9. Banci L, Bertini I, Cantini F, D'Onofrio M, and Viezzoli MS. Structure and dynamics of copper-free SOD: The protein before binding copper. Protein Sci 11: 2479-2492, 2002.
10. Banci L, Bertini I, Cramaro F, Del Conte R, and Viezzoli MS. Solution structure of Apo Cu,Zn superoxide dismutase: role of metal ions in protein folding. Biochemistry 42: 9543-9553, 2003.
11. Battistoni A, Mazzetti AP, and Rotilio G. In vivo formation of Cu,Zn superoxide dismutase disulfide bond in Escherichia coli. FEBS Lett 443: 313-316, 1999.
12. Battistoni A and Rotilio G. Isolation of an active and heat-stable monomeric form of Cu,Zn superoxide dismutase from the periplasmic space of Escherichia coli. FEBS Lett 374: 199-202, 1995.
13. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schussel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, and Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100: 14187-14192, 2003.
14. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, and Brown RH Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42: 644-654, 1997.
15. Beckman JS, Esetvez AG, Barbeito L, and Crow JP. CCS knockout mice establish an alternative source of copper for SOD in ALS. Free Radic Biol Med 33: 1433-1435, 2002.
16. Benov L, Sage H, and Fridovich I. The copper- and zinc-containing superoxide dismutase from Escherichia coli: molecular weight and stability. Arch Biochem Biophys 340: 305-310, 1997.
17. Bertinato J, Iskandar M, and L'Abbe MR. Copper deficiency induces the upregulation of the copper chaperone for Cu/Zn superoxide dismutase in weanling male rats. J Nutr 133: 28-31, 2003.
18. Bertini I, Mangani S, and Viezzoli MS. Structure and properties of copper-zinc superoxide dismutase. Adv Inorg Chem 45: 127-250, 1998.
19. Beyer WF, Jr., Fridovich I, Mullenbach GT, and Hallewell R. Examination of the role of arginine-143 in the human copper and zinc superoxide dismutase by site-specific mutagenesis. J Biol Chem 262: 11182-11187, 1987.
20. Bogdanov MB, Ramos LE, Xu Z, and Beal MF. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 71: 1321-1324, 1998.
21. Bordo D, Djinovic K, and Bolognesi M. Conserved patterns in the Cu,Zn superoxide dismutase family. J Mol Biol 238: 366-386, 1994.
22. Bowling AC, Barkowski EE, McKenna-Yasek D, Sapp P, Horvitz HR, Beal MF, and Brown RH, Jr. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 64: 2366-2369, 1995.
23. Brown NM, Torres AS, Doan PE, and O'Halloran TV. Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutase. Proc Natl Acad Sci USA 101: 5518-5523, 2004.
24. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price DL, and Cleveland DW. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 94: 7606-7611, 1997.
25. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, and Cleveland DW. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281: 1851-1854, 1998.
26. Bruijn LI, Miller TM, and Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749, 2004.
27. Cadenas E and Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29: 222-230, 2000.
28. Carroll MC, Girouard JB, Ulloa JL, Subramaniam JR, Wong PC, Valentine JS, and Culotta VC. Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. Proc Natl Acad Sci USA 101: 5964-5969, 2004.
29. Casareno RLB, Waggoner D, and Gitlin JD. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J Biol Chem 273: 23625-23628, 1998.
30. Chang LY, Slot JW, Geuze HJ, and Crapo JD. Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes. J Cell Biol 107: 2169-2179, 1988.
31. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, and Li L. Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280: 11648-11655, 2005.
32. Cleveland DW. Neuronal growth and death: order and disorder in the axoplasm. Cell 84: 663-666, 1996.
33. Corson LB, Strain JJ, Culotta VC, and Cleveland DW. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc Natl Acad Sci USA 95: 6361-6366, 1998.
34. Crow JP, Sampson JB, Zhuang Y, Thompson JA, and Beckman JS. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 69: 1936-1944, 1997.
35. Culotta VC, Joh HD, Lin SJ, Slekar KH, and Strain J. A physiological role for Saccharomyces cerevisiae copper/zinc superoxide dismutase in copper buffering. J Biol Chem 270: 29991-29997, 1995.
36. Culotta VC, Klomp LWJ, Strain J, Casareno RLB, Krems B, and Gitlin JD. The copper chaperone for superoxide dismutase. J Biol Chem 272: 23469-23472, 1997.
37. Dahlgren C and Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14, 1999.
38. Dameron CT and Harris ED. Regulation of aortic CuZn-superoxide dismutase with copper. Caeruloplasmin and albumin re-activate and transfer copper to the enzyme in culture. Biochem J 248: 669-675, 1987.
39. Davies KJ. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50: 279-289, 2000.
40. de Beus MD, Chung J, and Colon W. Modification of cysteine 111 in Cu/Zn superoxide dismutase results in altered spectroscopic and biophysical properties. Protein Sci 13: 1347-1355, 2004.
41. Eisses JF, Stasser JP, Ralle M, Kaplan JH, and Blackburn NJ. Domains I and III of the human copper chaperone for superoxide dismutase interact via a cysteine-bridged di-copper(I) cluster. Biochemistry 39: 7337-7342, 2000.
42. Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO, and Hart PJ. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 10: 461-467, 2003.
43. Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, Epstein CJ, and Huang TT. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24: 367-380, 2005.
44. Endo T, Fujii T, Sato K, Taniguchi N, and Fujii J. A pivotal role of Zn-binding residues in the function of the copper chaperone for SOD1. Biochem Biophys Res Commun 276: 999-1004, 2000.
45. Engidawork E and Lubec G. Protein expression in Down syndrome brain. Amino Acids 21: 331-361, 2001.
46. Ermilova IP, Ermilov VB, Levy M, Ho E, Pereira C, and Beckman JS. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Neurosci Lett 379: 42-46, 2005.
47. Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang YX, Richardson GJ, Tarpey MM, Barbeito L, and Beckman JS. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286: 2498-2500, 1999.
48. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Jr, and Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074, 1997.
49. Field LS, Furukawa Y, O'Halloran TV, and Culotta VC. Factors controlling the uptake of yeast copper/zinc superoxide dismutase into mitochondria. J Biol Chem 278: 28052-28059, 2003.
50. Fisher CL, Cabelli DE, Tainer JA, Hallewell RA, and Getzoff ED. The role of arginine 143 in the electrostatics and mechanism of Cu,Zn superoxide dismutase: computational and experimental evaluation by mutational analysis. Proteins 19: 24-34, 1994.
51. Forman HJ and Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J Biol Chem 248: 2645-2649, 1973.
52. Frand AR and Kaiser CA. Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol Cell 4: 469-477, 1999.
53. Fridovich I. Superoxide dismutases. Annu Rev Biochem 44: 147-159, 1975.
54. Furukawa Y and O'Halloran TV. ALS mutations have the greatest destabilizing effect on the apo, reduced form of SOD1, leading to unfolding and oxidative aggregation. J Biol Chem 280: 17266-17274, 2005.
55. Furukawa Y, Torres AS, and O'Halloran TV. Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 23: 2872-2881, 2004.
56. Galiazzo F, Ciriolo MR, Carri MT, Civitareale P, Marcocci L, Marmocchi F, and Rotilio G. Activation and induction by copper of Cu/Zn superoxide dismutase in Saccharomyces cerevisiae. Presence of an inactive proenzyme in anaerobic yeast. Eur J Biochem 196: 545-549, 1991.
57. Galiazzo F and Labbe-Bois R. Regulation of Cu,Zn- and Mn-superoxide dismutase transcription in Sacchammyces cerevisiae. FEBS Lett 315: 197-200, 1993.
58. Ghadge GD, Wang L, Sharma K, Monti AL, Bindokas V, Stevens FJ, and Roos RP. Truncated wild-type SOD1 and FALS-linked mutant SOD1 cause neural cell death in the chick embryo spinal cord. Neurobiol Dis 21: 194-205, 2005.
59. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 251: 8-28, 1995.
60. Goto Y and Hamaguchi K. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J Biochem (Tokyo) 86: 1433-1441, 1979.
61. Goto Y and Hamaguchi K. Formation of the intrachain disulfide bond in the constant fragment of the immunoglobulin light chain. J Mol Biol 146: 321-340, 1981.
62. Goto Y and Hamaguchi K. Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond. J Mol Biol 156: 911-926, 1982.
63. Gralla EB, Thiele DJ, Silar P, and Valentine JS. ACE1, a copper-dependent transcription factor, activates expression of the yeast copper, zinc superoxide dismutase gene. Proc Natl Acad Sci USA 88: 8558-8562, 1991.
64. Graumann J, Lilie H, Tang XL, Tucker KA, Hoffmann JT, Vijayalakshmi J, Saper M, Bardwell JCA, and Jakob U. Activation of the redox-regulated molecular chaperone Hsp33-A two-step mechanism. Structure 9: 377-387, 2001.
65. Gregory EM and Fridovic I. Oxygen toxicity and superoxide dismutase. J Bacteriol 114: 1193-1197, 1973.
66. Gregory EM, Goscin SA, and Fridovich I. Superoxide dismutase and oxygen toxicity in a eukaryote. J Bacteriol 117: 456-460, 1974.
67. Gross E, Kastner DB, Kaiser CA, and Pass D. Structure of Ero1p, source of disulfide bonds for oxidative protein folding in the cell. Cell 117: 601-610, 2004.
68. Gross E, Sevier CS, Vala A, Kaiser CA, and Pass D. A new FAD-binding fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p. Nat Struct Biol 9: 61-67, 2002.
69. Hall LT, Sanchez RJ, Holloway SP, Zhu HN, Stine JE, Lyons TJ, Demeler B, Schirf V, Hansen JC, Nersissian AM, Valentine JS, and Hart PJ. X-ray crystallographic and analytical ultracentrifugation analyses of truncated and full-length yeast copper chaperones for SOD (LYS7): A dimer-dimer model of LYS7-SOD association and copper delivery. Biochemistry 39: 3611-3623, 2000.
70. Hammarstrom P, Schneider F, and Kelly JW. Transsuppression of misfolding in an amyloid disease. Science 293: 2459-2462, 2001.
71. Han D, Williams E, and Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 353: 411-416, 2001.
72. Haskins K, Kench J, Powers K, Bradley B, Pugazhenthi S, Reusch J, and McDuffie M. Role for oxidative stress in the regeneration of islet beta cells? J Investig Med 52: 45-49, 2004.
73. Hayward LJ, Rodriguez JA, Kim JW, Tiwari A, Goto JJ, Cabelli DE, Valentine JS, and Brown RH, Jr. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 277: 15923-15931, 2002.
74. Hoffman PN and Lasek RJ. The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons. J Cell Biol 66: 351-366, 1975.
75. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
76. Hottinger AF, Fine EG, Gurney ME, Zurn AD, and Aebischer P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 9: 1548-1551, 1997.
77. Hough MA, Grossmann JG, Antonyuk SV, Strange RW, Doucette PA, Rodriguez JA, Whitson LJ, Hart PJ, Hayward LJ, Valentine JS, and Hasnain SS. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc Natl Acad Sci USA 101: 5976-5981, 2004.
78. Huie RE and Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
79. Hwang C, Sinskey AJ, and Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257: 1496-1502, 1992.
80. Ito K, Uchiyama T, Fukutake T, Arai K, Kanesaka T, and Hattori T. Different clinical phenotypes of siblings with familial amyotrophic lateral sclerosis showing Cys146Arg point mutation of superoxide dismutase 1 gene. Clinica Neurol 42: 175-177, 2002.
81. Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, and Holstege JC. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol Dis 1: 623-643, 2000.
82. Jakob U, Muse W, Eser M, and Bardwell JC. Chaperone activity with a redox switch. Cell 96: 341-352, 1999.
83. Jensen LT and Culotta VC. Activation of Cu/Zn superoxide dismutases from C. elegans does not require the copper chaperone CCS. J Biol Chem 280: 41373-41379, 2005.
84. Johnston JA, Dalton MJ, Gurney ME, and Kopito RR. Formation of high molecular weight complexes of mutant Cu,Zn- superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97: 12571-12576, 2000.
85. Jokic N, Di Scala F, Dupuis L, Rene F, Muller A, De Aguilar JL, and Loeffler JP. Early activation of antioxidant mechanisms in muscle of mutant Cu/Zn-superoxide dismutase-linked amyotrophic lateral sclerosis mice. Ann NY Acad Sci 1010: 552-556, 2003.
86. Juneja T, Pericak-Vance MA, Laing NG, Dave S, and Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology 48: 55-57, 1997.
87. Kagi JH and Schaffer A. Biochemistry of metallothionein. Biochemistry 27: 8509-8515, 1988.
88. Kato S, Sumi-Akamaru H, Fujimura H, Sakoda S, Kato M, Hirano A, Takikawa M, and Ohama E. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Acta Neuropathol 102: 233-238, 2001.
89. Kessova IG, Ho YS, Thung S and Cederbaum AI. Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase. Hepatology 38: 1136-1145, 2003.
90. Khare SD, Caplow M, and Dokholyan NV. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 101: 15094-15099, 2004.
91. Kroll JS, Langford PR, Wilks KE, and Keil AD. Bacterial [Cu,Zn]-superoxide dismutase: phylogenetically distinct from the eukaryotic enzyme, and not so rare after all! Microbiology 141: 2271-2279, 1995.
92. Kurobe N, Suzuki F, Okajima K, and Kato K. Sensitive enzyme immunoassay for human Cu/Zn superoxide dismutase. Clin Chim Acta 187: 11-20, 1990.
93. Laliberte J, Whitson LJ, Beaudoin J, Holloway SP, Hart PJ, and Labbe S. The Schizosaccharomyces pombe Pccs protein functions in both copper trafficking and metal detoxification pathways. J Biol Chem 279: 28744-28755, 2004.
94. Lamb AL, Torres AS, O'Halloran TV, and Rosenzweig AC. Heterodimer formation between superoxide dismutase and its copper chaperone. Biochemistry 39: 14720-14727, 2000.
95. Lamb AL, Torres AS, O'Halloran TV, and Rosenzweig AC. Heterodimeric structure of superoxide dismutase in complex with its metallochaperone. Nat Struct Biol 8: 751-755, 2001.
96. Lamb AL, Wernimont AK, Pufahl RA, Culotta VC, O'Halloran TV, and Rosenzweig AC. Crystal structure of the copper chaperone for superoxide dismutase. Nat Struct Biol 6: 724-729, 1999.
97. Lamb AL, Wernimont AK, Pufahl RA, O'Halloran TV, and Rosenzweig AC. Crystal structure of the second domain of the human copper chaperone for superoxide dismutase. Biochemistry 39: 1589-1595, 2000.
98. Lee JP, Gerin C, Bindokas VP, Miller R, Ghadge G, and Roos RP. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis. J Neurochem 82: 1229-1238, 2002.
99. Lee S and Eisenberg D. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat Struct Biol 10: 725-730, 2003.
100. Lindberg MJ, Tibell L, and Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc Natl Acad Sci USA 99: 16607-16612, 2002.
101. Lindenau J, Noack H, Possel H, Asayama K, and Wolf G. Cellular distribution of superoxide dismutases in the rat CNS. Glia 29: 25-34, 2000.
102. .: in vitro and in vivo. Free Radic Biol Med 16: 29-33, 1994.
103. Liu H, Zhu H, Eggers DK, Nersissian AM, Faull KF, Goto JJ, Ai J, Sanders-Loehr J, Gralla EB, and Valentine JS. Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry 39: 8125-8132, 2000.
104. Liu J, Lillo C, Jonsson PA, Velde CV, Ward CM, Miller TM, Subramaniam JR, Rothstein JD, Marklund S, Andersen PM, Brannstrom T, Gredal O, Wong PC, Williams DS, and Cleveland DW. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43: 5-17, 2004.
105. Liu SX, Fabisiak JP, Tyurin VA, Borisenko GG, Pitt BR, Lazo JS, and Kagan VE. Reconstitution of apo-superoxide dismutase by nitric oxide-induced copper transfer from metallothioneins. Chem Res Toxicol 13: 922-931, 2000.
106. Locker JK. and Griffiths G. An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J Cell Biol 144: 267-279, 1999.
107. Lyons TJ, Liu HB, Goto JJ, Nersissian A, Roe JA, Graden JA, Cafe C, Ellerby LM, Bredesen DE, Gralla EB, and Valentine JS. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sci USA 93: 12240-12244, 1996.
108. Maret W and Vallee BL. Cobalt as probe and label of proteins. Methods Enzymol 226: 52-71, 1993.
109. Matsumoto G, Stojanovic A, Holmberg CI, Kim S, and Morimoto RI. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171: 75-85, 2005.
110. Matzuk MM, Dionne L, Guo Q, Kumar TR, and Lebovitz RM. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 139: 4008-4011, 1998.
111. McCord JM and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969.
112. McFadden SL, Ding D, Reaume AG, Flood DG, and Salvi RJ. Age-related cochlear hair cell loss is enhanced in mice lacking copper/zinc superoxide dismutase. Neurobiol Aging 20: 1-8, 1999.
113. Mesecke N, Terziyska N, Kozany C, Baumann F, Neupert W, Hell K, and Herrmann JM. A disulfide relay system in the intermembrane space of mitochondria that mediates protein import. Cell 121: 1059-1069, 2005.
114. Moriwaki Y, Yamamoto T, Suda M, Nasako Y, Takahashi S, Agbedana OE, Hada T, and Higashino K. Purification and immunohistochemical tissue localization of human xanthine oxidase. Biochim Biophys Acta 1164: 327-330, 1993.
115. Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH Jr, and Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21: 9246-9254, 2001.
116. Nagano S, Ogawa Y, Yanagihara T, and Sakoda S. Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci Lett 265: 159-162, 1999.
117. Niwa J, Ishigaki S, Hishikawa N, Yamamoto M, Doyu M, Murata S, Tanaka K, Taniguchi N, and Sobue G. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J Biol Chem 277: 36793-36798, 2002.
118. Oeda T, Shimohama S, Kitagawa N, Kohno R, Imura T, Shibasaki H, and Ishii N. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet 10: 2013-2023, 2001.
119. Ogawa Y, Kosaka H, Nakanishi T, Shimizu A, Ohoi N, Shouji H, Yanagihara T, and Sakoda S. Stability of mutant superoxide dismutase-1 associated with familiar amyotrophic lateral sclerosis determines the manner of copper release and induction of thioredoxin in erythrocytes. Biochem Biophys Res Commun 241: 251-257, 1997.
120. O'Halloran TV and Culotta VC. Metallochaperones, an intracellular shuttle service for metal ions. J Biol Chem 275: 25057-25060, 2000.
121. Oh-ishi S, Kizaki T, Ookawara T, Sakurai T, Izawa T, Nagata N, and Ohno H. Endurance training improves the resistance of rat diaphragm to exercise-induced oxidative stress. Am J Respir Crit Care Med 156: 1579-1585, 1997.
122. Okado-Matsumoto A and Fridovich I. Amyotrophic lateral sclerosis: A proposed mechanism. Proc Natl Acad Sci USA 99: 9010-9014, 2002.
123. Okamoto K, Hirai S, Yamazaki T, Sun XY, and Nakazato Y. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 129: 233-236, 1991.
124. Ookawara T, Kawamura N, Kitagawa Y, and Taniguchi N. Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 267: 18505-18510, 1992.
125. Outten CE and O'Halloran TV. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science 292: 2488-2492, 2001.
126. Pacello F, Langford PR, Kroll JS, Indiani C, Smulevich G, Desideri A, Rotilio G, and Battistoni A. A novel heme protein, the Cu,Zn-superoxide dismutase from Haemophilus ducreyi. J Biol Chem 276: 30326-30334, 2001.
127. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, and Cleveland DW. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92: 954-958, 1995.
128. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, and Brown RH, Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43: 19-30, 2004.
129. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, and Nanji AA. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27: 1317-1323, 1998.
130. Prohaska JR and Brokate B. Lower copper, zinc-superoxide dismutase protein but not mRNA in organs of copper-deficient rats. Arch Biochem Biophys 393: 170-176, 2001.
131. Prohaska JR, Geissler J, Brokate B, and Broderius M. Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase. Exp Biol Med (Maywood) 228: 959-966, 2003.
132. Pufahl RA, Singer CP, Peariso KL, Lin SJ, Schmidt PJ, Fahrni CJ, Culotta VC, PennerHahn JE, and O'Halloran TV. Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science 278: 853-856, 1997.
133. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, and O'Halloran TV. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 284: 805-808, 1999.
134. Rae TD, Torres AS, Pufahl RA, and O'Halloran TV. Mechanism of Cu,Zn-superoxide dismutase activation by the human metallochaperone hCCS. J Biol Chem 276: 5166-5176, 2001.
135. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, and Chakrabartty A. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279: 15499-15504, 2004.
136. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, Cashman NR, Kondejewski LH, and Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 277: 47551-47556, 2002.
137. Ralle M, Lutsenko S, and Blackburn NJ. X-ray absorption spectroscopy of the copper chaperone HAH1 reveals a linear two-coordinate Cu(I) center capable of adduct formation with exogenous thiols and phosphines. J Biol Chem 278: 23163-23170, 2003.
138. Ray SS, Nowak RJ, Brown RH, Jr, and Lansbury PT, Jr. Small-molecule- mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc Natl Acad Sci USA 102: 3639-3644, 2005.
139. Ray SS, Nowak RJ, Strolovich K, Brown RH, Jr., Walz T, and Lansbury PT, Jr. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amyotrophic lateral sclerosis. Biochemistry 43: 4899-4905, 2004.
140. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Jr., Scott RW, and Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13: 43-47, 1996.
141. Ripps ME, Huntley GW, Hof PR, Morrison JH, and Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92: 689-693, 1995.
142. Robberecht W, Sapp P, Viaene MK, Rosen D, McKenna-Yasek D, Haines J, Horvitz R, Theys P, and Brown R, Jr. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 62: 384-387, 1994.
143. Rodriguez JA, Shaw BF, Durazo A, Sohn SH, Doucette PA, Nersissian AM, Faull KF, Eggers DK, Tiwari A, Hayward LJ, and Valentine JS. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc Natl Acad Sci USA 102: 10516-10521, 2005.
144. Rodriguez JA, Valentine OS, Eggers DK, Roe JA, Tiwari A, Brown RH, and Hayward LJ. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J Biol Chem 277: 15932-15937, 2002.
145. Roe JA, Butler A, Scholler DM, Valentine JS, Marky L, and Breslauer KJ. Differential scanning calorimetry of Cu,Zn-superoxide dismutase, the apoprotein, and its zinc-substituted derivatives. Biochemistry 27: 950-958, 1988.
146. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
147. Rothstein JD, Dykes-Hoberg M, Corson LB, Becker M, Cleveland DW, Price DL, Culotta VC, and Wong PC. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J Neurochem 72: 422-429, 1999.
148. Rush JW, Laughlin MH, Woodman CR, and Price EM. SOD-1 expression in pig coronary arterioles is increased by exercise training. Am J Physiol Heart Circ Physiol 279: H2068-H2076, 2000.
149. Rush JW, Turk JR, and Laughlin MH. Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium. Am J Physiol Heart Circ Physiol 284: H1378-H1387, 2003.
150. Schmidt PJ, Kunst C, and Culotta VC. Copper activation of superoxide dismutase 1 (SOD1) in vivo-Role for protein-protein interactions with the copper chaperone for SOD1. J Biol Chem 275: 33771-33776, 2000.
151. Schmidt PJ, Rae TD, Pufahl RA, Hamma T, Strain J, O'Halloran TV, and Culotta VC. Multiple protein domains contribute to the action of the copper chaperone for superoxide dismutase. J Biol Chem 274: 23719-23725, 1999.
152. Senkevich TG, White CL, Koonin EV, and Moss B. A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc Natl Acad Sci USA 97: 12068-12073, 2000.
153. Shibata N, Asayama K, Hirano A, and Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 18: 492-498, 1996.
154. Shibata N, Hirano A, Kobayashi M, Sasaki S, Kato T, Matsumoto S, Shiozawa Z, Komori T, Ikemoto A, Umahara T, et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 179: 149-152, 1994.
155. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng HX, Hung WY, Kato T, and Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55: 481-490, 1996.
156. Shinder GA, Lacourse MC, Minotti S, and Durham HD. Mutant
157. Silahtaroglu AN, Brondum-Nielsen K, Gredal O, Werdelin L, Panas M, Petersen MB, Tommerup N, and Tumer Z. Human CCS gene: genomic organization and exclusion as a candidate for amyotrophic lateral sclerosis (ALS). BMC Genet 3: 5, 2002.
158. Son M, Cloyd CD, Rothstein JD, Rajendran B, and Elliott JL. Aggregate formation in Cu,Zn superoxide dismutase-related proteins. J Biol Chem 278: 14331-14336, 2003.
159. Southon A, Burke R, Norgate M, Batterham P, and Camakaris J. Copper homoeostasis in Drosophila melanogaster S2 cells. Biochem J 383: 303-309, 2004.
160. Spagnolo L, Toro I, D'Orazio M, O'Neill P, Pedersen JZ, Carugo O, Rotilio G, Battistoni A, and Djinovic-Carugo K. Unique features of the sodC-encoded superoxide dismutase from Mycobacterium tuberculosis, a fully functional copper-containing enzyme lacking zinc in the active site. J Biol Chem 279: 33447-33455, 2004.
161. St John G and Steinman HM. Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survival. J Bacteriol 178: 1578-1584, 1996.
162. Stasser JP, Eisses JF, Barry AN, Kaplan JH, and Blackburn NJ. Cysteine-to-serine mutants of the human copper chaperone for superoxide dismutase reveal a copper cluster at a domain III dimer interface. Biochemistry 44: 3143-3152, 2005.
163. Stathopulos PB, Rumfeldt JA, Scholz GA, Irani RA, Frey HE, Hallewell RA, Lepock JR, and Meiering EM. Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro. Proc Natl Acad Sci USA 100: 7021-7026, 2003.
164. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, and Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8: 85-92, 2005.
165. Strange RW, Antonyuk S, Hough MA, Doucette PA, Rodriguez JA, Hart PJ, Hayward LJ, Valentine JS, and Hasnain SS. The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J Mol Biol 328: 877-891, 2003.
166. Sturtz LA, Diekert K, Jensen LT, Lill R, and Culotta VC. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem 276: 38084-38089, 2001.
167. Subramaniam JR, Lyons WE, Liu J, Bartnikas TB, Rothstein J, Price DL, Cleveland DW, Gitlin JD, and Wong PC. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci 5: 301-307, 2002.
168. Suzuki KT and Kuroda T. Direct transfer of copper from metallothionein to superoxide dismutase: a possible mechanism for differential supply of Cu to SOD and ceruloplasmin in LEC rats. Res Commun Mol Pathol Pharmacol 86: 15-23, 1994.
169. Suzuki KT and Kuroda T. Transfer of copper and zinc from ionic and metallothionein-bound forms to Cu, Zn-superoxide dismutase. Res Commun Mol Pathol Pharmacol 87: 287-296, 1995.
170. Tainer JA, Getzoff ED, Richardson JS, and Richardson DC. Structure and mechanism of copper, zinc superoxide dismutase. Nature 306: 284-287, 1983.
171. Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, and Nukina N. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10: 148-154, 2004.
172. Tatzelt J, Prusiner SB, and Welch WJ. Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J 15: 6363-6373, 1996.
173. Teoh ML, Walasek PJ, and Evans DH. Leporipoxvirus Cu,Zn-superoxide dismutase (SOD) homologs are catalytically inert decoy proteins that bind copper chaperone for SOD. J Biol Chem 278: 33175-33184, 2003.
174. Thornton JM. Disulphide bridges in globular proteins. J Mol Biol 151: 261-287, 1981.
175. Thorpe C, Hoober KL, Raje S, Glynn NM, Burnside J, Turi GK, and Coppock DL. Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys 405: 1-12, 2002.
176. Tiwari A and Hayward LJ. Familial ALS mutants of Cu/Zn superoxide dismutase are susceptible to disulfide reduction. J Biol Chem 278: 5984-5992, 2003.
177. Tiwari A, Xu Z, and Hayward LJ. Aberrantly increased hydrophobicity shared by mutants of Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. J Biol Chem 280: 29771-29779, 2005.
178. Tsuda T, Munthasser S, Fraser PE, Percy ME, Rainero I, Vaula G, Pinessi L, Bergamini L, Vignocchi G, McLachlan DR, et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 13: 727-736, 1994.
179. Tu BP and Weissman JS. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164: 341-346, 2004.
180. Tummala H, Jung C, Tiwari A, Higgins CM, Hayward LJ, and Xu Z. Inhibition of chaperone activity is a shared property of several Cu,Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis. J Biol Chem 280: 17725-17731, 2005.
181. Tyler DD. Polarographic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem J 147: 493-504, 1975.
182. Urushitani M, Kurisu J, Tateno M, Hatakeyama S, Nakayama K, Kato S, and Takahashi R. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem 90: 231-244, 2004.
183. Urushitani M, Kurisu J, Tsukita K, and Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J Neurochem 83: 1030-1042, 2002.
184. Vijayvergiya C, Beal MF, Buck J, and Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 25: 2463-2470, 2005.
185. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, and Borchelt DR. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12: 2753-2764, 2003.
186. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, and Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8: 933-941, 2001.
187. Wei JPJ, Srinivasan C, Han H, Valentine JS, and Gralla EB. Evidence for a novel role of copper-zinc superoxide dismutase in zinc metabolism. J Biol Chem 276: 44798-44803, 2001.
188. West EC and Prohaska JR. Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp Biol Med (Maywood) 229: 756-764, 2004.
189. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, and Bredesen DE. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518, 1996.
190. Williamson TL and Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2: 50-56, 1999.
191. Wintz H and Vulpe C. Plant copper chaperones. Biochem Soc Trans 30: 732-735, 2002.
192. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, and Price DL. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116, 1995.
193. Wong PC, Waggoner D, Subramaniam JR, Tessarollo L, Bartnikas TB, Culotta VC, Price DL, Rothstein J, and Gitlin JD. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci USA 97: 2886-2891, 2000.
194. Zhang H, Andrekopoulos C, Joseph J, Crow J, and Kalyanaraman B. The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and alpha-synuclein: intermediacy of tryptophan- and tyrosine-derived oxidation products. Free Radic Biol Med 36: 1355-1365, 2004.
195. Zhang Q and Kelly JW. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 42: 8756-8761, 2003.
196. Zhu HN, Shipp E, Sanchez RJ, Liba A, Stine JE, Hart PJ, Gralla EB, Nersissian AM, and Valentine JS. Cobalt(2+) binding to human and tomato copper chaperone for superoxide dismutase: implications for the metal ion transfer mechanism. Biochemistry 39: 5413-5421, 2000.